- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization ; volume:10 ; number:5 ; day:17 ; month:7 ; year:2020 ; pages:903-915 ; date:10.2020
Dermatology and therapy ; 10, Heft 5 (17.7.2020), 903-915, 10.2020
- Creator
-
Piquero-Casals, Jaime
Morgado-Carrasco, Daniel
Gilaberte, Yolanda
Rio, Rubén Del
Macaya-Pascual, Antonio
Granger, Corinne
López-Estebaranz, José Luis
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-020-00425-4
- URN
-
urn:nbn:de:101:1-2020102721491344452912
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Piquero-Casals, Jaime
- Morgado-Carrasco, Daniel
- Gilaberte, Yolanda
- Rio, Rubén Del
- Macaya-Pascual, Antonio
- Granger, Corinne
- López-Estebaranz, José Luis
- SpringerLink (Online service)
Other Objects (12)
Proper management of suspicious actinic cheilitis
Actinic keratosis metrics
Pearls on glaucoma management
Pearls of glaucoma management
Actinic keratosis : 4 tables
Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Diagnosis and therapy of actinic keratosis
Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series
Cold Atmospheric Plasma (CAP) for the Treatment of Actinic Keratosis and Skin Field Cancerization: Clinical and High-Frequency Ultrasound Evaluation
Proper management of suspicious actinic cheilitis
Actinic keratosis metrics
Pearls on glaucoma management
Pearls of glaucoma management
Actinic keratosis : 4 tables
Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Diagnosis and therapy of actinic keratosis
Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series
Cold Atmospheric Plasma (CAP) for the Treatment of Actinic Keratosis and Skin Field Cancerization: Clinical and High-Frequency Ultrasound Evaluation
Proper management of suspicious actinic cheilitis
Actinic keratosis metrics
Pearls on glaucoma management
Pearls of glaucoma management
Actinic keratosis : 4 tables
Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Diagnosis and therapy of actinic keratosis
Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series